U.S. Markets close in 1 hr 50 mins

Medical Cannabis Business Could Be a Huge Windfall for Investors

Adam Jones
Medical Cannabis Business Could Be a Huge Windfall for Investors

Aphria Thinks the US Cannabis Market Could Hit $50 Billion(Continued from Prior Part)## Growth opportunityWhile recreational cannabis has gained publicity, the medical cannabis business could lead to a huge windfall for investors. Initially, the market size for medical cannabis could be much larger than recreational cannabis. Currently, recreational cannabis is only legal in two countries. For companies like Canopy Growth (WEED), Cronos Group (CRON), HEXO (HEXO), and CannTrust (CNTTF), selling in states where cannabis is legal isn’t an option. Under the US federal law, recreational cannabis still isn’t legal.## Medical to legalize firstMedical cannabis will likely be legalized in the country. Most countries aren’t open to the idea of recreational cannabis. So, the initial momentum will likely come from exploring medical uses. Canopy Growth has a presence in international markets through medical products.Even in the United States, companies are exploring opportunities to grow the cannabis market from the medical angle. If cannabis (MJ) helps alleviate medical conditions, regulators might be more open to allowing medical cannabis products for society’s greater good.We’ll continue to monitor and discuss medical cannabis developments.Browse this series on Market Realist: * Part 1 - Aphria Thinks the US Cannabis Market Could Hit $50 Billion * Part 2 - Cannabis Industry: What Can Investors Expect? * Part 3 - Cannabis Stocks: What Strong Economic Activity Indicates